Research with a destination | A question to investigate
Before changing the process, know what the measurement means.
A process improvement can disappear when the units, sampling or comparison change. Our industrial research interest is in measurements that help medicines businesses decide whether an apparent improvement is real, repeatable and worth pursuing.
Give the measurement a defined boundary.
The initial inputs would describe the material or process, the sampling point, the period observed and the unit of comparison. A change per batch may differ from a change per accepted unit of product. A lower input quantity may be offset by rework elsewhere. We would establish what is included and excluded before comparing options, then examine whether existing records are sufficiently complete to support the intended analysis without inventing missing observations.
Compare against a reference with known limitations.
A proposed study could compare an emerging method with an established measurement or an independently checked reference. The reference itself may have uncertainty, so agreement should not be treated as a simple pass or fail without context. Repeated measurements, relevant operating conditions and plausible failure cases would inform the design. The comparator would be selected for the intended decision, rather than because it is the easiest method available to demonstrate a difference.
Turn uncertainty into something an operator can use.
A technical uncertainty estimate is valuable only if it changes the interpretation of the result. We would ask whether the observed difference is large enough to matter operationally and whether measurement variation could reverse the conclusion. The proposed output could show a range of plausible values, the conditions affecting that range and the next measurement needed to narrow it. A single precise-looking number should not conceal that the decision remains unresolved.
A public decision brief | An illustrative example
Open the question.
Inspect the reasoning.
Choose a business question, then look beneath its claim. See what a public source supports, what depends on the local setting and what a useful next step could be.
An academic or development team examining the next experiment after a published model comparison.
What does this result allow us to ask next?
A promising figure can sharpen a research question. Its value depends on keeping the model, observation and next hypothesis distinct.
A proposition to investigate
A clearer question can be a useful output.
An evidence brief could help a team distinguish a published observation from the experiment needed to investigate translation. The proposed value is a more precise comparison and an explicit evidence gap. It does not turn an external model result into a clinical claim or a NEUVIOR discovery.
This is a constructed research-planning question, not an agreed study or product-development result.
What the next brief would contain
A decision someone
can commission.
- The decision
- Whether a specific follow-on question has a credible experimental comparison.
- The comparator
- A scientifically justified model or condition relevant to the proposed hypothesis.
- The evidence
- Full methods, model relevance, measurements, replication and a feasible authorised protocol.
- Stop or redesign
- Stop or redesign if the proposed model cannot answer the question or the required work is not feasible.
Constructed public example | Not PHARMORIS-generated software output or a measured customer result.
Keep this example briefConnect the research to the process without skipping stages.
NPL's good-practice guidance supplies measurement context; FDA's process-validation guidance supplies medicines-manufacturing context (National Physical Laboratory, n.d.; FDA, n.d.). Their relevance would be assessed for the actual method and process. A feasibility result would not qualify a production process or replace an organisation's quality system. Any later use in manufacturing decisions would require the appropriate expertise, controls and permissions, with responsibility clear between the process owner, the measurement provider and the research team.
Make the economics part of the question.
A more accurate method can still be impractical if it slows production, requires extensive training or consumes scarce specialist capacity. We would consider the full effort of sampling, analysis, maintenance and interpretation alongside performance. A useful partner could bring a specific unresolved measurement problem and permission to examine it. NEUVIOR's proposed role is to help frame the evidence and decision, with specialist laboratory work commissioned or collaborated on only where explicitly agreed.
A first study should remove one uncertainty.
The bounded proposal is one measurement challenge, one credible reference and a defined operating range. It should produce an interpretable comparison and a recommendation to adopt further testing, refine the method or stop. We would pause if the reference cannot be characterised, the sampling cannot represent the process or the likely improvement is too small to justify the operational burden. The next investment should follow what the measurement can actually support, including an inconvenient null result.
The decision record could show how much uncertainty can be tolerated before an operator would choose a different action. This makes the measurement specification economically meaningful: the aim is sufficient confidence for the intended decision, rather than pursuing an expensive degree of precision that cannot change it.
Sources and context
National Physical Laboratory (n.d.) Good practice guides. Available at: https://www.npl.co.uk/resources/gpgs (Accessed: 14 October 2026).
FDA (n.d.) Process Validation: General Principles and Practices. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/process-validation-general-principles-and-practices (Accessed: 14 October 2026).
Another useful angle.
- AI and professional judgement
Examine how professionals check, challenge and use AI outputs in medicines work, with proposed studies of appropriate reliance, review quality and total effort.
- Public involvement in research
Shape medicines research with the people affected, through proposed public-involvement partnerships that offer clear influence, support and feedback on decisions.
- Evidence review quality
Explore a proposed medicines evidence study comparing source fidelity, review quality and total checking effort, with a clear decision for research partners.
